direct-acting antiviral agents (DAAs) – Page 3 – SASHA: South Australian Sexual Health Awareness

Australian Health Organisations refute Cochrane Review Report and affirm efficacy of DAA therapy for hepatitis C

1 Min Read

A

Joint position statement, Australia, June 2017 This joint Position Statement aims to strongly refute and reject the findings of the Cochrane Review report titled Direct-acting antivirals for chronic hepatitis C, published by the Cochrane Hepato‐Biliary Group on 6 June 2017. The Position Statement was prepared by the expert panel who published a Consensus Statement for Australian recommendations...

Read on Read later

Hepatitis C treatment can be provided successfully at syringe programme sites

By J Pope

In Hepatitis, People Who Inject Drugs / AOD

1 Min Read

H

infohep.org, 18 April 2017
Administering direct-acting antiviral therapy for people who inject drugs at a syringe exchange site led to high sustained response rates in a pilot study in New York City. Expanding treatment for this population could reduce hepatitis C virus (HCV) transmission and ultimately help eliminate hepatitis C as a public health threat.

Latest research shows Australia on track to cure Hepatitis C

By J Pope

In Hepatitis, People Who Inject Drugs / AOD

1 Min Read

L

Kirby Institute/UNSW – 21 February 2017
More Australians were treated for their hepatitis C infection in the first year new generation hepatitis C regimens were made available on the Pharmaceutical Benefits Schemes than in the past decade, according to a new report released today by the Kirby Institute at UNSW Sydney.

Read more here
Download report (PDF) here

Read on Read later

Tagdirect-acting antiviral agents (DAAs)